Alliance Foundation Trials, Llc.
Clinical trials sponsored by Alliance Foundation Trials, Llc., explained in plain language.
-
New combo therapy shows promise for recurrent prostate cancer
Disease control CompletedThis study tested if adding two newer drugs (apalutamide and abiraterone) to standard hormone therapy could better control prostate cancer that has returned after surgery. 504 men with a fast-rising PSA took part. The goal was to see how long the cancer stayed under control, but …
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 17, 2026 10:08 UTC
-
New hope for hard-to-treat myeloma: drug trio shows promise in early trial
Disease control CompletedThis early-phase study tested a combination of three drugs (ibrutinib, lenalidomide, and dexamethasone) in 14 adults with multiple myeloma that had returned or stopped responding to prior treatments. The main goal was to find safe doses and identify side effects. While the approa…
Phase: PHASE1 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC